ResearcherThe University of OsakaActive in the last 2 years
Akira Kikuchi
Matched on ORCID iD 0000-0003-3378-9522; OpenAlex author ID A5088956313. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers
Papers 4
- Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling. Last author DOI 10.1111/cas.16278↗
- Role of Wnt5b-Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1111/gtc.13115↗
- Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. Last author DOI 10.7554/elife.66721↗
- CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy. Last author DOI 10.1158/1078-0432.ccr-18-2124↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akikazu Harada · 2 shared papers, 2021–2024 · strength 0.43
- Ryota Sada · 2 shared papers, 2019–2024 · strength 0.36
- Paper Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling. DOI 10.1111/cas.16278↗
- Paper CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy. DOI 10.1158/1078-0432.ccr-18-2124↗
- Hidetoshi Eguchi · 2 shared papers, 2019–2021 · strength 0.23
- Paper Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. DOI 10.7554/elife.66721↗
- Paper CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy. DOI 10.1158/1078-0432.ccr-18-2124↗
- Koki Kamizaki · 1 shared paper, 2024 · strength 0.22
- Natsuko Yamauchi · 1 shared paper, 2024 · strength 0.22
- Atsuhiro Masuda · 1 shared paper, 2024 · strength 0.22
- Yuzo Kodama · 1 shared paper, 2024 · strength 0.22
- Tsunekazu Mizushima · 1 shared paper, 2019 · strength 0.08
- Soichiro Mori · 1 shared paper, 2019 · strength 0.08
- Hirokazu Kimura · 1 shared paper, 2019 · strength 0.08
- Tetsuo Takehara · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.